Aflatoxin B1 and M1: Biological Properties and Their Involvement in Cancer Development

Overview

Journal Toxins (Basel)

Publisher MDPI

Specialty Toxicology

Date 2018 May 26

PMID 29794965

Citations 140

Authors

Silvia Marchese

Andrea Polo

Andrea Ariano

Salvatore Velotto

Susan Costantini

Lorella Severino

Affiliations

Soon will be listed here.

Abstract

Aflatoxins are fungal metabolites found in feeds and foods. When the ruminants eat feedstuffs containing Aflatoxin B1 (AFB1), this toxin is metabolized and Aflatoxin M1 (AFM1) is excreted in milk. International Agency for Research on Cancer (IARC) classified AFB1 and AFM1 as human carcinogens belonging to Group 1 and Group 2B, respectively, with the formation of DNA adducts. In the last years, some epidemiological studies were conducted on cancer patients aimed to evaluate the effects of AFB1 and AFM1 exposure on cancer cells in order to verify the correlation between toxin exposure and cancer cell proliferation and invasion. In this review, we summarize the activation pathways of AFB1 and AFM1 and the data already reported in literature about their correlation with cancer development and progression. Moreover, considering that few data are still reported about what genes/proteins/miRNAs can be used as damage markers due to AFB1 and AFM1 exposure, we performed a bioinformatic analysis based on interaction network and miRNA predictions to identify a panel of genes/proteins/miRNAs that can be used as targets in further studies for evaluating the effects of the damages induced by AFB1 and AFM1 and their capacity to induce cancer initiation.

Citing Articles

Peanuts ( L.) and Mycotoxins: Analytical Approaches, Prevalence, and Innovative Detoxification.

Melo B, Robalo J, Ramos F, Sanches Silva A Foods. 2025; 14(5).

PMID: 40077605 PMC: 11898414. DOI: 10.3390/foods14050902.

Aflatoxin B1 Exposure Suppresses the Migration of Dendritic Cells by Reshaping the Cytoskeleton.

Tang K, Tian J, Xu Y, Shang G, Peng X, Yue P Int J Mol Sci. 2025; 26(4).

PMID: 40004187 PMC: 11854954. DOI: 10.3390/ijms26041725.

An untargeted metabolomic analysis of acute AFB1 treatment in liver, breast, and lung cells.

Cao H, Molina S, Sumner S, Rushing B PLoS One. 2025; 20(1):e0313159.

PMID: 39883710 PMC: 11781672. DOI: 10.1371/journal.pone.0313159.

A Landscape of Cancer Initiation and Cancer Stem Cells.

Seno M Cancers (Basel). 2025; 17(2).

PMID: 39857984 PMC: 11764454. DOI: 10.3390/cancers17020203.

Spatial Distribution and Dietary Risk Assessment of Aflatoxins in Raw Milk and Dairy Feedstuff Samples from Different Climate Zones in China.

Yang X, Liu B, Zhang L, Wang X, Xie J, Liang J Toxins (Basel). 2025; 17(1).

PMID: 39852994 PMC: 11769556. DOI: 10.3390/toxins17010041.

References

Pondugula S, Pavek P, Mani S . Pregnane X Receptor and Cancer: Context-Specificity is Key. Nucl Receptor Res. 2016; 3. PMC: 5017004. DOI: 10.11131/2016/101198. View

. Aflatoxins. IARC Monogr Eval Carcinog Risks Hum. 1993; 56:245-395. PMC: 7681273. View

Luongo D, Russo R, Balestrieri A, Marzocco S, Bergamo P, Severino L . In vitro study of AFB1 and AFM1 effects on human lymphoblastoid Jurkat T-cell model. J Immunotoxicol. 2013; 11(4):353-8. DOI: 10.3109/1547691X.2013.848250. View

Jebali R, Abbes S, Ben Salah-Abbes J, Ben Younes R, Haous Z, Oueslati R . Ability of Lactobacillus plantarum MON03 to mitigate aflatoxins (B1 and M1) immunotoxicities in mice. J Immunotoxicol. 2014; 12(3):290-9. DOI: 10.3109/1547691X.2014.973622. View

Song Y, Shiota M, Kuroiwa K, Naito S, Oda Y . The important role of glycine N-methyltransferase in the carcinogenesis and progression of prostate cancer. Mod Pathol. 2011; 24(9):1272-80. DOI: 10.1038/modpathol.2011.76. View

Kim J, Park S, Do K, Kim D, Moon Y . Interference with mutagenic aflatoxin B1-induced checkpoints through antagonistic action of ochratoxin A in intestinal cancer cells: a molecular explanation on potential risk of crosstalk between carcinogens. Oncotarget. 2016; 7(26):39627-39639. PMC: 5129958. DOI: 10.18632/oncotarget.8914. View

Sklan D, Shelly M, Makovsky B, Geyra A, Klipper E, Friedman A . The effect of chronic feeding of diacetoxyscirpenol and T-2 toxin on performance, health, small intestinal physiology and antibody production in turkey poults. Br Poult Sci. 2003; 44(1):46-52. DOI: 10.1080/0007166031000085373. View

Eaton D, Gallagher E . Mechanisms of aflatoxin carcinogenesis. Annu Rev Pharmacol Toxicol. 1994; 34:135-72. DOI: 10.1146/annurev.pa.34.040194.001031. View

Meissonnier G, Laffitte J, Loiseau N, Benoit E, Raymond I, Pinton P . Selective impairment of drug-metabolizing enzymes in pig liver during subchronic dietary exposure to aflatoxin B1. Food Chem Toxicol. 2007; 45(11):2145-54. DOI: 10.1016/j.fct.2007.05.012. View

10.

Guindon K, Foley J, Maronpot R, Massey T . Failure of catalase to protect against aflatoxin B1-induced mouse lung tumorigenicity. Toxicol Appl Pharmacol. 2007; 227(2):179-83. DOI: 10.1016/j.taap.2007.10.015. View

11.

Gao Y, Li S, Wang J, Luo C, Zhao S, Zheng N . Modulation of Intestinal Epithelial Permeability in Differentiated Caco-2 Cells Exposed to Aflatoxin M1 and Ochratoxin A Individually or Collectively. Toxins (Basel). 2017; 10(1). PMC: 5793100. DOI: 10.3390/toxins10010013. View

12.

MERKOW L, EPSTEIN S, SLIFKIN M, Pardo M . The ultrastructure of renal neoplasms induced by aflatoxin B1. Cancer Res. 1973; 33(7):1608-14. View

13.

Harrison J, Carvajal M, Garner R . Does aflatoxin exposure in the United Kingdom constitute a cancer risk?. Environ Health Perspect. 1993; 99:99-105. PMC: 1567057. DOI: 10.1289/ehp.939999. View

14.

Du W, Fang L, Li M, Yang X, Liang Y, Peng C . MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling. J Cell Sci. 2013; 126(Pt 6):1440-53. DOI: 10.1242/jcs.118299. View

15.

Yen C, Hung J, Ueng Y, Liu S, Chen S, Liu H . Glycine N-methyltransferase affects the metabolism of aflatoxin B1 and blocks its carcinogenic effect. Toxicol Appl Pharmacol. 2009; 235(3):296-304. DOI: 10.1016/j.taap.2008.12.013. View

16.

Schmitt D, Madeira da Silva L, Zhang W, Liu Z, Arora R, Lim S . ErbB2-intronic microRNA-4728: a novel tumor suppressor and antagonist of oncogenic MAPK signaling. Cell Death Dis. 2015; 6:e1742. PMC: 4669696. DOI: 10.1038/cddis.2015.116. View

17.

Eom S, Yim D, Zhang Y, Yun J, Moon S, Yun H . Dietary aflatoxin B1 intake, genetic polymorphisms of CYP1A2, CYP2E1, EPHX1, GSTM1, and GSTT1, and gastric cancer risk in Korean. Cancer Causes Control. 2013; 24(11):1963-72. DOI: 10.1007/s10552-013-0272-3. View

18.

Wogan G, Paglialunga S . Carcinogenicity of synthetic aflatoxin M1 in rats. Food Cosmet Toxicol. 1974; 12(3):381-4. DOI: 10.1016/0015-6264(74)90012-1. View

19.

Zhu L, Gao J, Huang K, Luo Y, Zhang B, Xu W . miR-34a screened by miRNA profiling negatively regulates Wnt/β-catenin signaling pathway in Aflatoxin B1 induced hepatotoxicity. Sci Rep. 2015; 5:16732. PMC: 4645126. DOI: 10.1038/srep16732. View

20.

Marrone A, Tryndyak V, Beland F, Pogribny I . MicroRNA Responses to the Genotoxic Carcinogens Aflatoxin B1 and Benzo[a]pyrene in Human HepaRG Cells. Toxicol Sci. 2015; 149(2):496-502. DOI: 10.1093/toxsci/kfv253. View